Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,463.3
-22.4 (-0.90%)

 

  • STI Straits Times Index
    2,463.3
    -22.4 (-0.90%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,505.8
    6.3 (0.42%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    23,716.8
    -233.8 (-0.98%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,274.3
    -42.6 (-1.29%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,360.3
    40.9 (0.18%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,934.1
    -65.3 (-1.31%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,096.3M
  • Value: 1,292.5M
  • Rise: 147
  • Fall: 168
  • Unch: 468

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sembcorp Marine0.145-0.006
Vicplas Intl0.440+0.130
Medtecs Intl1.180+0.170
Singtel2.160-0.050
Alset0.064-
ThaiBev0.590-0.005
Aspen0.185+0.033
Jiutian Chemical0.045+0.002
QT Vascular0.007-
Rex Intl0.145+0.004

World Indices

World Indices
Name Last Change
Nasdaq 10,778.8 -14.5
HSI 23,716.8 -233.8
HSCEI 9,576.8 -63.6
Jakarta 4,934.1 -65.3
Nikkei 225 23,360.3 +40.9
SSE Comp 3,274.3 -42.6
Shanghai A 3,431.6 -44.7
Shanghai B 248.9 -2.5
KOSPI 2,332.6 -56.8

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

FORTE BIOSCIENCES INC FORTE BIOSCIENCES
Updated on 21 Sep 2020 (End of trading day)
Last (USD): 42.000 Change: -7.510 High: 51.487 Remarks: -
Change (%): -15.17 Low: 41.840
Open 49.120 Yesterday's Close 49.51
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 141,271 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -5.66864 Trailing EPS (USD) e -6.63635 NAV (USD) b 2.2203
PE a - Trailing PE f - Price / NAV b 18.9164
Dividend (USD) d - Cash In Hand (USD) g 2.4765 Issued & Paid-up Shares c 11,204,800
Dividend Yield (%) d - Price / Cash In Hand g 16.959 Treasury Shares h -
Market Cap (M) 470.602 Enterprise Value (M) 442.853
Piotroski F Score 1 Exchange Code FBRX Par Value ( $ ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 92.6
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 11 Aug 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 16 Jun 2020.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference FORTE BIOSCIENCES INC NASDAQ 470.602 - - 18.9164 -
Industry Biotechnology NASDAQ 2,713.650 631.603 6455.431 6.6642 0.664
Local Peer AMGEN INC NASDAQ 142,434.924 18.163 19.514 13.3629 2.408
Local Peer GILEAD SCIENCES INC NASDAQ 80,501.361 14.946 - 4.4656 3.963
Local Peer VERTEX PHARMACEUTICAL NASDAQ 68,763.288 58.432 33.047 9.1450 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 59,122.018 27.943 19.816 6.5275 -
Local Peer BIOGEN INC NASDAQ 42,475.378 7.213 7.167 3.7560 -
Local Peer ILLUMINA INC NASDAQ 39,536.227 39.457 57.051 8.6645 -
Local Peer SEATTLE GENETICS INC NASDAQ 31,115.884 - - 17.1525 -
Local Peer MODERNA INC NASDAQ 27,329.096 - - 9.2739 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 24,505.080 - - 9.6618 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 24,490.391 10.186 28.945 2.3345 -
Local Peer IMMUNOMEDICS INC NASDAQ 19,743.119 - - 33.2762 -
Local Peer INCYTE CORPORATION NASDAQ 18,674.708 41.787 - 7.9650 -
Other Local Peers BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), 10X GENOMICS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), NOVAVAX INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), IMMUNOVANT INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), ALKERMES PLC (NASDAQ), VAXCYTE INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), KODIAK SCIENCES INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), ALLOVIR INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), EDITAS MEDICINE INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), VERACYTE INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), UNIQURE N.V. (NASDAQ), KURA ONCOLOGY INC (NASDAQ), CORTEXYME INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), MACROGENICS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), VIELA BIO INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), COMPUGEN (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), NKARTA INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), ARVINAS INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), ALECTOR INC (NASDAQ), VAXART INC (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), RETROPHIN INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), PERSONALIS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), AKOUOS INC (NASDAQ), NANTKWEST INC (NASDAQ), AGENUS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), PRECIGEN INC (NASDAQ), OMEROS CORP (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), IMMUNOGEN INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), INHIBRX INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), GERON CORP (NASDAQ), XBIOTECH INC (NASDAQ), IMMATICS N V (NASDAQ), HUMANIGEN INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), AVROBIO INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), ARDELYX INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), IVERIC BIO INC (NASDAQ), ATRECA INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), MANNKIND CORPORATION (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), TREVENA INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), ATHERSYS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), KAMADA (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), PDL BIOPHARMA INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), MERUS B V (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), IMV INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), CHIASMA INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), AFFIMED N V (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), CABALETTA BIO INC (NASDAQ), NEXTCURE INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), MEDICINOVA INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), VERASTEM INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), ADURO BIOTECH INC (NASDAQ), XOMA CORP (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), CHIMERIX INC (NASDAQ), OTONOMY INC (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), EQUILLIUM INC (NASDAQ), SESEN BIO INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), INMUNE BIO INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), CELYAD ONCOLOGY ADS EACH REPR 1 ORD (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), INFLARX N V (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), VACCINEX INC (NASDAQ), ORGENESIS INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), ARAVIVE INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), BIONANO GENOMICS INC (NASDAQ), EVOGENE LTD (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), SYNLOGIC INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), ADICET BIO INC (NASDAQ), SAVARA INC (NASDAQ), BIOVIE INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), CURIS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), COHBAR INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), SOLIGENIX INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), RECRO PHARMA INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), OCUGEN INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), ATYR PHARMA INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), PRECIPIO INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), BIOCARDIA INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), ADVAXIS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), HISTOGEN INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), SENESTECH INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ)
Global Peer AMGEN-T HKEx 1,083,533.900 17.635 19.045 13.1159 2.480
Global Peer CSL ASX 130,265.197 41.534 41.534 13.7401 1.025
Global Peer WUXI BIO HKEx 252,515.756 219.661 175.369 16.9043 -
Global Peer BEIGENE HKEx 186,859.980 - - 9.5058 -
Global Peer SINO BIOPHARM HKEx 163,814.168 53.373 59.565 4.7445 0.612
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 5,292.490 97.110 31.077 4.4148 -
Global Peer Lonza SGX 5,940.891 6.617 5.028 0.6269 4.784
Global Peer GENSCRIPT BIO HKEx 21,591.858 - - 2.9531 -
Global Peer 3SBIO HKEx 21,518.433 19.489 14.331 1.8396 -
Global Peer VIVA BIOTECH HKEx 18,150.709 60.204 - 8.7251 0.172
Other Global Peers MESOBLAST LTD (ASX), MYOVANT SCIENCES LTD (NYSE), HAOHAI BIOTEC (HKEx), ALPHAMAB-B (HKEx), ARCUS BIOSCIENCES INC (NYSE), POLYNOVO LIMITED (ASX), FRONTAGE (HKEx), ASCENTAGE-B (HKEx), KADMON HLDGS INC (NYSE), KINTOR PHARMA-B (HKEx), DPHARMA (Bursa), SINOMAB BIO-B (HKEx), ASCLETIS-B (HKEx), LEE'S PHARM (HKEx), ESSEX BIO-TECH (HKEx), TELIX PHARMACEUTIC (ASX), PFENEX INC (NYSE American), NANOVIRICIDES INC (NYSE American), IBIO INC (NYSE American), NEXT SCIENCE LTD (ASX), LINEAGE CELL THERAPEUTICS INC (NYSE American), IMUGENE LIMITED (ASX), CEL-SCI CORP (NYSE American), ENZO BIOCHEM INC (NYSE), UNI-BIO GROUP (HKEx), NEUREN PHARMACEUTICALS LTD (ASX), ANTEOTECH LIMITED (ASX), IMMUTEP LTD (ASX), CYNATA THERAPEUTICS LTD (ASX), AIM IMMUNOTECH INC (NYSE American), BIONOMICS LTD (ASX), PALATIN TECHNOLOGIES INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), KAZIA THERAPEUTICS LIMITED (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), ARMATA PHARMACEUTICALS INC (NYSE American), MEMPHASYS LTD (ASX), 22ND CENTURY GROUP INC (NYSE American), GENETIC TECHNOLOGIES (ASX), INVEX THERAPEUTICS LTD NPV (ASX), BIOTRON (ASX), CT ENTERPRISE (HKEx), ALTERITY THERAPEUTICS LIMITED (ASX), REGENEUS LTD (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), ORAGENICS INC (NYSE American), REGENT PACIFIC (HKEx), Suntar Eco-City (SGX), BIOSINO BIO-TEC (HKEx), PRESCIENT THERAPEUTICS LIMITED (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), RHINOMED LIMITED (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), ADALTA LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), PATRYS LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), AUSTRALIAN PRIMARY HEMP LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), ANATARA LIFESCIENCES LTD (ASX), CRYOSITE (ASX), LIVING CELL TECHNOLOGIES (ASX), NANOLLOSE LTD (ASX), LEAF RESOURCES LTD (ASX), HAO WEN HLDGS (HKEx), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.390
+0.94 %
10 Days -+12.950
+44.58 %
20 Days -+15.740
+59.94 %
Medium Term Return 3 Months -+26.410
+169.40 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 13.350 - 52.833 Change From 1 Year Low +28.650 % Change From 1 Year Low (%) +214.61
Change From 1 Year High -10.833 % Change From 1 Year High (%) -20.50
2 Years Range 13.350 - 52.833 Change From 2 Years Low +28.650 % Change From 2 Years Low (%) +214.61
Change From 2 Years High -10.833 % Change From 2 Years High (%) -20.50
5 Years Range 13.350 - 52.833 Change From 5 Years Low +28.650 % Change From 5 Years Low (%) +214.61
Change From 5 Years High -10.833 % Change From 5 Years High (%) -20.50
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Forte Biosciences, Inc. engages in the development of biopharmaceutical products. It is a clinical stage dermatology company focuses in the treatment of inflammatory skin diseases. It offers FB-401, a live bio-therapeutic product. The company was founded by Paul A. Wagner in 2017 and is headquartered in Torrance, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
21 Sep 2020 49.120 51.487 41.840 42.000 141,271 -
18 Sep 2020 46.240 52.700 46.240 49.510 327,477 -
17 Sep 2020 42.780 52.833 42.780 47.500 313,681 -
16 Sep 2020 42.040 44.315 41.610 43.710 110,721 -
15 Sep 2020 41.250 44.739 40.130 41.610 87,120 -
14 Sep 2020 36.730 43.430 36.730 40.420 162,618 -
11 Sep 2020 35.950 37.490 35.155 35.910 83,765 -
10 Sep 2020 33.510 37.990 32.000 35.340 167,022 -
09 Sep 2020 29.230 32.000 29.020 31.800 89,355 -
08 Sep 2020 25.520 30.000 25.520 29.050 85,800 -
04 Sep 2020 27.700 28.710 24.550 26.630 77,038 -
03 Sep 2020 28.640 28.640 26.322 27.540 60,783 -
02 Sep 2020 30.490 30.590 28.000 28.710 50,615 -
01 Sep 2020 32.330 32.900 28.122 30.170 101,118 -
31 Aug 2020 30.000 31.570 30.000 31.250 68,679 -
28 Aug 2020 28.500 32.710 28.010 29.860 121,126 -
27 Aug 2020 27.400 27.850 26.200 26.690 44,629 -
26 Aug 2020 26.270 28.090 24.300 27.040 116,722 -
25 Aug 2020 27.610 29.700 26.260 26.260 266,280 -
24 Aug 2020 22.120 25.490 22.120 24.700 127,709 -
21 Aug 2020 21.780 22.630 21.092 22.190 32,574 -
20 Aug 2020 22.150 22.660 21.890 22.040 13,088 -
Summary
Current 2 Weeks
(08 Sep 2020 to 21 Sep 2020)
25.520 52.833 25.520 42.000 1,568,830 -
Previous 2 Weeks
(24 Aug 2020 to 04 Sep 2020)
22.120 52.833 22.120 26.630 1,034,699 -
4 Weeks from
(27 Jul 2020 to 21 Aug 2020)
21.270 52.833 20.529 22.190 963,198 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.